DK1061948T3 - Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf - Google Patents

Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf

Info

Publication number
DK1061948T3
DK1061948T3 DK99909234T DK99909234T DK1061948T3 DK 1061948 T3 DK1061948 T3 DK 1061948T3 DK 99909234 T DK99909234 T DK 99909234T DK 99909234 T DK99909234 T DK 99909234T DK 1061948 T3 DK1061948 T3 DK 1061948T3
Authority
DK
Denmark
Prior art keywords
preparation
polypeptide
physiologically active
sustained
active polypeptide
Prior art date
Application number
DK99909234T
Other languages
English (en)
Inventor
Yutaka Yamagata
Masafumi Misaki
Susumu Iwasa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK1061948T3 publication Critical patent/DK1061948T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK99909234T 1998-03-20 1999-03-18 Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf DK1061948T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7185398 1998-03-20
PCT/JP1999/001359 WO1999048519A1 (en) 1998-03-20 1999-03-18 Sustained-release preparation of physiologically active polypeptide and production thereof

Publications (1)

Publication Number Publication Date
DK1061948T3 true DK1061948T3 (da) 2003-03-31

Family

ID=13472521

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99909234T DK1061948T3 (da) 1998-03-20 1999-03-18 Præparat til vedvarende frigivelse af et fysiologisk aktivt polypeptid samt fremstilling deraf

Country Status (12)

Country Link
US (1) US6482864B1 (da)
EP (1) EP1061948B1 (da)
KR (1) KR20010042079A (da)
CN (1) CN1301172A (da)
AT (1) ATE230274T1 (da)
AU (1) AU744354B2 (da)
BR (1) BR9908936A (da)
CA (1) CA2324568A1 (da)
DE (1) DE69904701T2 (da)
DK (1) DK1061948T3 (da)
WO (1) WO1999048519A1 (da)
ZA (1) ZA200004597B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021187A1 (en) * 1999-09-17 2001-03-29 Takeda Chemical Industries, Ltd. Process for producing protein powder
WO2002043709A1 (fr) 2000-12-01 2002-06-06 Takeda Chemical Industries, Ltd. Procede de production d'une preparation contenant une substance bioactive
EP1356809A4 (en) * 2000-12-28 2008-05-14 Takeda Pharmaceutical Sustained release preparations
WO2002085399A1 (fr) * 2001-04-20 2002-10-31 Takeda Chemical Industries, Ltd. Preparations contenant un peptide
CN1310671C (zh) * 2001-07-09 2007-04-18 安斯泰来制药有限公司 缓释注射剂用组合物的制造方法
KR100684682B1 (ko) * 2002-09-24 2007-02-22 아사히 가세이 케미칼즈 가부시키가이샤 글리콜산 공중합체 및 그의 제조 방법
JP2007514752A (ja) * 2003-12-16 2007-06-07 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス Ｇｌｐ−１医薬組成物
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
MX2008001468A (es) * 2005-06-30 2008-04-07 Sod Conseils Rech Applic Composiciones farmaceuticas del peptido similar al glucagon-1.
US20070004616A1 (en) * 2005-06-30 2007-01-04 Roland Cherif-Cheikh GLP-1 pharmaceutical compositions
US20080292680A1 (en) * 2007-05-14 2008-11-27 Sustained Nano Systems Llc Hypercompressed polymer particles for controlled release ophthalmic medications
US8071119B2 (en) 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
WO2010123563A2 (en) * 2009-04-23 2010-10-28 Sustained Nano Systems Llc Controlled release dispensing device
CN102145160A (zh) * 2011-03-07 2011-08-10 深圳市健元医药科技有限公司 一种lhrh拮抗剂注射用的缓释植入制剂
CN102580056B (zh) * 2011-12-16 2014-04-09 深圳市健元医药科技有限公司 一种含抗利尿成分的缓释注射剂及其制备方法
CN113695370B (zh) * 2021-08-30 2022-06-07 河北科技大学 一种天然低共熔离子液体及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
ATE99546T1 (de) 1989-05-01 1994-01-15 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekuelen.
FR2658432B1 (fr) 1990-02-22 1994-07-01 Medgenix Group Sa Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
US5478564A (en) 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
ES2127835T3 (es) 1992-10-26 1999-05-01 Sanol Arznei Schwarz Gmbh Procedimiento para la preparacion de microcapsulas.
JPH08503950A (ja) 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
US6087324A (en) * 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
NZ260909A (en) 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
DE69632684T2 (de) * 1995-06-27 2005-06-09 Takeda Pharmaceutical Co. Ltd. Verfahren zur herstellung von zubereitungen mit verzögerter freisetzung
US6190702B1 (en) 1996-03-28 2001-02-20 Takeda Chemical Industries, Ltd. Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase
EP0946169B1 (en) 1996-12-20 2003-02-26 Takeda Chemical Industries, Ltd. Method of producing a sustained-release preparation
US6287587B2 (en) 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying

Also Published As

Publication number Publication date
CA2324568A1 (en) 1999-09-30
EP1061948B1 (en) 2003-01-02
EP1061948A1 (en) 2000-12-27
ZA200004597B (en) 2002-02-27
AU744354B2 (en) 2002-02-21
WO1999048519A1 (en) 1999-09-30
KR20010042079A (ko) 2001-05-25
DE69904701D1 (de) 2003-02-06
BR9908936A (pt) 2005-10-25
US6482864B1 (en) 2002-11-19
ATE230274T1 (de) 2003-01-15
DE69904701T2 (de) 2003-11-06
CN1301172A (zh) 2001-06-27
AU2853399A (en) 1999-10-18

Similar Documents

Publication Publication Date Title
ATE230274T1 (de) Physiologisch aktives polypeptid enthaltende zubereitung mit verzögerter freisetzung und deren herstellung
DK0946169T3 (da) Fremgangsmåde til fremstilling af et præparat med vedvarende frigivelse
DK0862418T3 (da) Fremgangsmåde til fremstilling af morphologisk ensartede mikrokapsler såvel som mikrokapsler fremstillet efter denne fremgangsmåde
NO972608D0 (no) Opplösningshjelpemidler for hydrofile makromolekyler
DK0436370T3 (da) Farmaceutisk præparat til kontrolleret afgivelse og fremgangsmåde til fremstilling deraf
GR920100323A (el) Μία μέ?οδος παρασκευής μικροσφαιρίων αποτελούμενων από ένα βιοαποικοδομούμενο πολυμερικό υλικό.
ES2113371T3 (es) Transformacion de celulas epidermicas de tejidos animales con la ayuda de particulas.
BR0115730A (pt) materiais antimicrobianos foto-estabilizados
ATE184480T1 (de) Verfahren zur herstellung von arzneizubereitungen mit verzögerter wirkstoffabgabe
NO993709D0 (no) Stabilisert blanding omfattende fibrinogen
ATE110965T1 (de) Impfstoffe gegen hämophilus influenzae.
CA2076010A1 (fr) Microspheres, leur procede de preparation et leur utilisation
GB2314508A (en) Diamide-dicarboxylic acid microspheres
ES2076412T3 (es) Proceso para la fabricacion de microesferas.
EA200000154A1 (ru) Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях
CY1109207T1 (el) Διαδικασια εχινοκανδινης
EP1258254A4 (en) COMPOSITIONS FOR DELAYED DELIVERY OF PHYSIOLOGICALLY ACTIVE COMPOUNDS THAT ARE LOW WATER-SOLUBLE, METHOD FOR THE PRODUCTION AND USE THEREOF
ATE103976T1 (de) Verfahren zur verkapselung.
DE602004020632D1 (de) Verfahren zur herstellung einer alpha-1-antitrypsinlösung
HUP9801521A2 (hu) Javított tulajdonságú bevonatos peszticid hatású mátrixok, eljárás előállításukra és ilyeneket tartalmazó készítmények
DE50007153D1 (de) 3d-matrix zur herstellung von zelltransplantaten
ES2163038T3 (es) Procedimiento para la preparacion de clavulanato de potasio.
ES2185373T3 (es) Encapsulacion de peptidos solubles en agua.
DK0615746T3 (da) Vandigt liposomsystem og fremgangsmåde til fremstilling af et sådant liposomsystem
IE45285L (en) Polyribonucleotides.